By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Canary Capital has made history with the filing of the first-ever staked Injective exchange-traded fund (ETF) with the US Securities and Exchange Commission (SEC). The filing has sent the INJ price on a meteoric rally, with the asset gaining nearly 5% in the last 24 hours. Canary Capital Eyes INJ ETF Approval According to a
The post Just In: Canary Capital Files For First Injective ETF, INJ Price Up appeared first on CoinGape.